Literature DB >> 11986958

All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation.

C Rybner1, J Hillion, T Sahraoui, M Lanotte, J Botti.   

Abstract

The cellular prion protein (PrPc) is a sialoglycoprotein involved in the pathogenesis of prion diseases. It has been identified at the plasma membrane of several cell types. All-trans retinoic acid (ATRA) is known to induce differentiation of human leukemia cell lines in vitro. PrPc messenger ribonucleic acid (mRNA) and protein are down-regulated upon ATRA-induced differentiation of HL60 cells. In this report, we have investigated the regulation of PrPc mRNA and protein expression during ATRA-treatment of maturation-sensitive (NB4) and -resistant (NB4-R1 and NB4-R2) cell lines. In ATRA-induced maturation of NB4 cells, down-regulation of PrPc mRNA and protein were observed. We also show that down-regulation of PrPc mRNA is dependent on protein synthesis. Moreover, the same down-regulation of prion protein by ATRA was observed at the surface of maturation-resistant, ATRA-responsive NB4-R1 cells. In contrast, the maturation-resistant and ATRA-unresponsive NB4-R2 subline showed no variation in membrane prion protein expression. These results demonstrate a dissociation between the regulation of prion protein expression by ATRA and the process of granulocyte maturation. We propose that retinoids should be investigated further as a preventive strategy to slow down prion disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986958     DOI: 10.1038/sj.leu.2402443

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  Activation and repression of prion protein expression by key regions of intron 1.

Authors:  Josephine A Wright; Patrick C McHugh; Mark Stockbridge; Samantha Lane; Silvia Kralovicova; David R Brown
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

2.  RARB and STMN2 polymorphisms are not associated with sporadic Creutzfeldt-Jakob disease (CJD) in the Korean population.

Authors:  Byung-Hoon Jeong; Hae-Jung Kim; Kyung-Hee Lee; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

3.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

4.  A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.

Authors:  Ruiqi Zhu; Weiwei Zhao; Fengjuan Fan; Liang Tang; Jingdi Liu; Ting Luo; Jun Deng; Yu Hu
Journal:  Oncotarget       Date:  2017-06-13

5.  Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interference.

Authors:  Daniel Heinzer; Merve Avar; Daniel Patrick Pease; Ashutosh Dhingra; Jiang-An Yin; Elke Schaper; Berre Doğançay; Marc Emmenegger; Anna Spinelli; Kevin Maggi; Andra Chincisan; Simon Mead; Simone Hornemann; Peter Heutink; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2021-10-27       Impact factor: 6.823

6.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

7.  Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases.

Authors:  Urmila Basu; Le Luo Guan; Stephen S Moore
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

8.  Regulation of prion protein expression: a potential site for therapeutic intervention in the transmissible spongiform encephalopathies.

Authors:  C L Haigh; D R Brown
Journal:  Int J Biomed Sci       Date:  2006-12

Review 9.  Prion disease and the innate immune system.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.